Jiajun Wen
“I think one of the most important things is that before you decide what you want to do, really just think about what you don’t want to do and what kind of lifestyle you don’t want to be in.”
Bloomberg School of Public Health
Epidemiology, ScD 2021
Senior Equity Research Associate at Jefferies
Jiajun‘s Podcast Episode
In this episode, we discuss what drew Jiajun to the investment banking world after completing his doctorate in Epidemiology, what his day-to-day work looks like researching publicly traded biotech companies at Jefferies, and his take on the importance of gaining a big-picture understanding of your field and being able to simply and effectively explain your research for transitioning from academia into industry.
Learn More About Jiajun‘s Story
I earned my Doctor of Science degree in Epidemiology from the Bloomberg School of Public Health in 2021, where my research focused on clinical trial design and meta-analysis of therapeutics for various diseases. I launched my career in medical affairs at Becton Dickinson before transitioning to a biotech equity analyst role at Jefferies, where I am responsible for evaluating multiple factors that impact the valuation of a biotech company, including preclinical and clinical data, regulatory approvals, financial position, competitive landscape, and commercial strategies, etc. I am deeply passionate about staying up-to-date on the latest technologies and therapies in the field and generating investment ideas that bring substantial returns to investors. A fun fact is that I have attended more medical meetings as an equity analyst than I did during my doctoral training.
I am a cat lover and proud owner of three former strays who have become part of my family. I’m also an avid baseball fan and just as zealous about analyzing baseball players and games as I am about valuing biotech companies. Whether I’m sifting through clinical data or breaking down a player’s stats, I love the challenge of finding patterns and insights that others may overlook.
